How long does short‑acting Adderall (mixed amphetamine salts) last?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Short-Acting Adderall

Short-acting Adderall (immediate-release mixed amphetamine salts) lasts approximately 4 to 6 hours, with effects beginning within 30 minutes of ingestion and reaching peak effectiveness within 1 to 3 hours 1.

Pharmacodynamic Profile

The immediate-release formulation of mixed amphetamine salts follows a predictable time course:

  • Onset of action: 30 minutes after oral administration
  • Peak plasma concentration: Approximately 3 hours post-dose 2
  • Peak behavioral effects: 1 to 3 hours after ingestion
  • Duration of therapeutic effect: 4 to 6 hours 1
  • Elimination half-life: 9.77 to 11 hours for d-amphetamine; 11.5 to 13.8 hours for l-amphetamine 2

Important distinction: While the plasma half-life extends beyond 9-11 hours, the therapeutic effects on ADHD symptoms disappear well before the medication leaves the plasma—a phenomenon called "clockwise hysteresis" 1. This means symptom control ends at 4-6 hours despite detectable drug levels remaining in the bloodstream.

Clinical Implications

Multiple Daily Dosing Required

Because of the short duration, most patients require 2-3 doses per day to maintain symptom control throughout waking hours 1. The guideline evidence indicates that plasma level troughs occur at the most problematic times—lunchtime, recess, or during the bus ride home from school 1.

Timing Considerations

  • First dose: Typically taken upon waking to provide coverage for morning activities
  • Second dose: Usually needed 4 hours after the first dose to maintain afternoon coverage
  • Third dose (if needed): May be required for homework or evening activities

Common Pitfalls

The "roller-coaster effect" is a well-documented challenge with immediate-release formulations 1. Patients experience:

  • Rapid onset of symptom control
  • Peak effectiveness for 1-3 hours
  • Gradual decline in efficacy
  • Complete loss of effect by 4-6 hours
  • Potential "rebound" symptoms during wear-off periods

This pattern, combined with missed doses and irregular compliance, frequently complicates treatment 1.

Comparison to Extended-Release Formulations

For context, extended-release Adderall (Adderall XR) provides approximately 12 hours of coverage through a dual-release mechanism 3, 4. The XR formulation releases half the dose immediately and the remaining half approximately 4 hours later, effectively mimicking two doses of immediate-release medication given 4 hours apart 3, 5.

The extended-release option addresses the practical challenges of in-school dosing, reduces the risk of peer ridicule, and improves medication adherence—all significant concerns with short-acting formulations 1.

Factors Affecting Duration

Urinary pH significantly impacts amphetamine elimination 2. Alkaline urine results in less ionization and reduced renal elimination, potentially prolonging effects. Conversely, acidic urine and high flow rates increase renal elimination. This is why certain foods, beverages (like citrus juices), and medications that alter urinary pH can affect how long the medication works.

Related Questions

Why does immediate-release Adderall (mixed amphetamine salts) cause headaches?
For a patient taking 30 mg of immediate‑release Adderall (mixed amphetamine salts) who still experiences evening crashes, what medication can be used to prevent these crashes?
A patient taking Adderall XR (mixed amphetamine salts extended‑release) 20 mg reports that the medication does not last through an eight‑hour work shift; how can the dose or regimen be adjusted to provide adequate coverage?
A patient taking Adderall (mixed amphetamine salts) reports facial redness, feeling hot, and a strange sensation; what should they do?
What are the indications, dosing regimen, contraindications, and common adverse effects of Adderall ER (extended‑release mixed amphetamine salts) 20 mg?
What is the appropriate dexamethasone dosing regimen for managing cancer‑related bone pain in a hospice patient?
What alternative medication can be used instead of Duracef (cefuroxime axetil)?
In an 85‑year‑old patient with bradycardia who is taking losartan, hydrochlorothiazide, and hydralazine, should a clonidine transdermal patch be used to prevent a rapid drop in blood pressure?
Do my positive anti‑RNP antibodies, elevated CK, proximal muscle weakness, and MRI showing nonspecific T2 hyperintensity in the cervical spinal cord and cerebellar white matter suggest an autoimmune demyelinating disorder, and what is the likely diagnosis and prognosis?
In pediatric patients, at what age and under which conditions should ranitidine (H2‑blocker) or omeprazole (proton‑pump inhibitor) be administered as pre‑operative acid‑suppressing medication?
What medications are appropriate for a defiant 12-year-old child?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.